Document:

Exhibit 10.1

 

Execution Version

 

SECOND AMENDMENT

 

SECOND AMENDMENT TO CREDIT AGREEMENT (this “Second Amendment”), dated as of October 28, 2015 among Envision Healthcare Corporation (the “Borrower”), the several banks and financial institutions parties hereto that constitute Tranche B-2 Term Lenders (as further defined in Subsection 1(b)(i) hereof) and Deutsche Bank AG New York Branch, as Administrative Agent (the “Administrative Agent”).  Unless otherwise indicated, all capitalized terms used herein and not otherwise defined shall have the respective meanings provided to such terms in the Credit Agreement referred to below (as amended by this Second Amendment).

 

W I T N E S S E T H :

 

WHEREAS, the Borrower, the Lenders from time to time party thereto and the Administrative Agent are parties to a Credit Agreement, dated as of May 25, 2011 (as amended, supplemented, waived or otherwise modified from time to time, the “Credit Agreement”);

 

WHEREAS, pursuant to that certain agreement and plan of merger dated as of July 30, 2015 (the “Merger Agreement”), by and among AMR HoldCo, Inc. (“Buyer”), Ranch Merger Sub, Inc. (“Merger Sub”), WP Rocket Holdings Inc. (“Target”) and Fortis Advisors LLC (the “Merger Agreement”), the Borrower will acquire all of the equity interest of the Target through the merger of Merger Sub with and into the Target, with the Target surviving the Merger as a wholly owned subsidiary of the Borrower (the “Acquisition”); and

 

WHEREAS, pursuant to and in accordance with Subsection 2.6 of the Credit Agreement, the Borrower has requested that Incremental Term Loan Commitments in an aggregate principal amount of $635 million be made available to the Borrower, and the Tranche B-2 Term Lenders and the Administrative Agent have agreed, upon the terms and subject to the conditions set forth herein, (a) that the Tranche B-2 Term Lenders will make Incremental Term Loans in the form of the Tranche B-2 Term Loans (as defined in Subsection 1(b)(i) hereof), (b) that the proceeds of the Tranche B-2 Term Loans will be used to finance the Acquisition and to pay fees, premiums and expenses incurred in connection with the Acquisition and this Amendment and (c) to amend the Credit Agreement as provided herein without the consent or approval of any other Lender, as permitted by Subsections 2.6(d) and 11.1(d) thereof.

 

NOW, THEREFORE, in consideration of the foregoing, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby agree as follows:

 

SECTION ONE - Credit Agreement Amendments.  Subject to the satisfaction of the conditions set forth in Section Two hereof:

 

(a)                                 The Tranche B-2 Term Loans shall be deemed to be “Incremental Term Loans”, the Tranche B-2 Term Lenders shall be deemed to be “Additional Lenders”, the Tranche B-2 Term Loan Commitments shall be deemed to be “Incremental Term Loan Commitments” and this Second Amendment shall be deemed to be an “Incremental Commitment Amendment” and a “Loan Document”, in each case, for all purposes of the Credit Agreement and the other 

 

 

Loan Documents.  The Borrower and the Administrative Agent hereby consent, pursuant to Subsections 11.6(b)(i) and 2.6(b) of the Credit Agreement, to the inclusion as an “Additional Lender” of each Tranche B-2 Term Lender that is party to this Second Amendment that is not an existing Lender, an Affiliate of an existing Lender or an Approved Fund.

 

(b)                                 Subsection 1.1 of the Credit Agreement is hereby amended as follows:

 

i.                                          by adding the following new definitions, to appear in proper alphabetical order:

 

“Initial Term Lender”:  any Lender having an Initial Term Loan Commitment or an Initial Term Loan outstanding hereunder.

 

“Initial Term Loan Percentage”:  as to any Initial Term Lender at any time, the percentage which (a) such Lender’s Initial Term Loans and unused Initial Term Loan Commitment then outstanding constitute of (b) the sum of all of the Initial Term Loans and unused Initial Term Loan Commitments then outstanding (or, if the Initial Term Loan Commitments have terminated or expired in their entirety, the percentage which such Lender’s Initial Term Loans then outstanding constitute of the aggregate Initial Term Loans then outstanding).

 

“Original Lead Arrangers”:  as defined in the definition of Lead Arrangers in this Subsection 1.1.

 

“Second Amendment”:  the Second Amendment to Credit Agreement, dated as of the Second Amendment Effective Date, among the Borrower, the Tranche B-2 Term Lenders and the Administrative Agent.

 

“Second Amendment Effective Date”:  October 28, 2015.

 

“Tranche B-2 Fee Letter”:  the fee letter agreement, dated as of July 30, 2015 by and among Barclays Bank PLC, Goldman Sachs Bank USA and the Borrower, as supplemented by the letter agreement dated August 28, 2015, as further supplemented and amended by the letter agreement dated September 3, 2015, as further supplemented by the letter agreement dated October 28, 2015 and as further amended, restated, modified or supplemented from time to time.

 

“Tranche B-2 Lead Arrangers”:  as defined in the definition of “Lead Arrangers” in this Subsection 1.1.

 

“Tranche B-2 Term Lender”:  any Lender having a Tranche B-2 Term Loan Commitment and/or a Tranche B-2 Term Loan outstanding hereunder.

 

“Tranche B-2 Term Loan”:  the Tranche B-2 Term Loans made by the Lenders holding the Tranche B-2 Term Loan Commitments to the Borrower under Article II on the Second Amendment Effective Date.

 

2

 

“Tranche B-2 Term Loan Commitment”:  as to any Lender, its obligation to make Tranche B-2 Term Loans to the Borrower pursuant to Subsection 2.1(b) in an aggregate amount not to exceed at any one time outstanding the amount set forth opposite such Lender’s name in Schedule A-1 under the heading “Tranche B-2 Term Loan Commitment” or, in the case of any Lender that is an Assignee, the amount of the assigning Lender’s Tranche B-2 Term Loan Commitment assigned to such Assignee pursuant to Subsection 11.6(b) (in each case as such amount may be adjusted from time to time as provided herein); collectively, as to all Lenders, the “Tranche B-2 Term Loan Commitments”.  The original aggregate amount of the Tranche B-2 Term Loan Commitments on the Second Amendment Effective Date is $635 million.

 

“Tranche B-2 Term Loan Percentage”:  as to any Tranche B-2 Term Lender at any time, the percentage which (a) such Lender’s Tranche B-2 Term Loans and unused Tranche B-2 Term Loan Commitment then outstanding constitute of (b) the sum of all of the Tranche B-2 Term Loans and unused Tranche B-2 Term Loan Commitments then outstanding (or, if the Tranche B-2 Term Loan Commitments have terminated or expired in their entirety, the percentage which such Lender’s Tranche B-2 Term Loans then outstanding constitutes of the aggregate Tranche B-2 Term Loans then outstanding).

 

“Tranche B-2 Repricing Transaction”:  the prepayment, refinancing, substitution or replacement of all or a portion of the Tranche B-2 Term Loans (including, without limitation, as may be effected through any amendment, waiver or modification to this Agreement relating to the interest rate for, or weighted average yield of, the Tranche B-2 Term Loans), (a) if the primary purpose of such prepayment, refinancing, substitution, replacement, amendment, waiver or modification is (as reasonably determined by the Borrower in good faith) to refinance the Tranche B-2 Term Loans at a lower “effective yield” (taking into account, among other factors, margin, upfront or similar fees or original issue discount shared with all providers of such financing, but excluding the effect of any arrangement, commitment, underwriting, structuring, syndication or other fees payable in connection therewith that are not shared with all providers of such financing, and without taking into account any fluctuations in the Adjusted LIBOR Rate, but including any LIBOR floor or similar floor that is higher than the then Adjusted LIBOR Rate), (b) if the prepayment, refinancing, substitution, replacement, amendment, waiver or modification is effectuated by the incurrence by the Borrower or any Restricted Subsidiary of new Indebtedness, such new Indebtedness is first lien secured term loan bank financing, and (c) if such prepayment, refinancing, substitution, replacement, amendment, waiver or modification results in such first lien secured term loan bank financing having an “effective yield” (as reasonably determined by the Administrative Agent, in consultation with the Borrower, consistent with generally accepted financial practices, after giving effect to, among other factors, margin, upfront or similar fees or original issue discount shared with all providers of such financing (calculated based on assumed four-year average life and without present value 

 

3

 

discount), but  excluding the effect of any arrangement, commitment, underwriting, structuring, syndication or other fees payable in connection therewith that are not shared with all providers of such financing, and without taking into account any fluctuations in the Adjusted LIBOR Rate, but including any LIBOR floor or similar floor that is higher than the then applicable Adjusted LIBOR Rate) that is less than the “effective yield” (as reasonably determined by the Administrative Agent, in consultation with the Borrower, on the same basis) of the Tranche B-2 Term Loans prior to being so prepaid, refinanced, substituted or replaced or subject to such amendment, waiver or modification to this Agreement.

 

ii.                                       by inserting the words “(i) in respect of the Initial Term Loans, “ before “1.00%” appearing in clause (b) of the definition of “Adjusted LIBOR Rate” and by inserting the words “and (ii) in respect of the Tranche B-2 Term Loans, 1.00%” after “1.00%” appearing in clause (b) of the definition of “Adjusted LIBOR Rate”,

 

iii.                                    by inserting the words “(i) in respect of the Initial Term Loans, “ before “2.00%” appearing in clause (d) of the definition of “Alternate Base Rate” and by inserting the words “and (ii) in respect of the Tranche B-2 Term Loans, 2.00%” after “2.00%” appearing in clause (d) of the definition of “Alternate Base Rate”,

 

iv.                                   by amending and restating the definition of “Applicable Margin” as follows:

 

““Applicable Margin”:  in respect of (I) Initial Term Loans, a percentage per annum equal to (a) from the First Amendment Effective Date until the first Business Day that immediately follows the date on which a Compliance Certificate is delivered pursuant to Subsection 7.2(b) in respect of the first full fiscal quarter ending after the First Amendment Effective Date, 3.00% per annum for Eurodollar Loans, and 2.00% per annum for ABR Loans, and (b) thereafter, the applicable percentage per annum set forth below, as determined by reference to the Consolidated First-Lien Net Leverage Ratio, as set forth in the most recent Compliance Certificate received by the Administrative Agent pursuant to Subsection 7.2(b):

 

Applicable Margin

 

	
Pricing Level
    	
 
    	
Consolidated
   First-Lien Net
   Leverage Ratio
    	
 
    	
Eurodollar Loans
    	
 
    	
ABR Loans
    	
 
    
	
1
    	
 
    	
< 2.50:1.00
    	
 
    	
2.75
    	
%
    	
1.75
    	
%
    
	
2
    	
 
    	
> 2.50:1.00
    	
 
    	
3.00
    	
%
    	
2.00
    	
%
    

 

4

 

and (II) Tranche B-2 Term Loans, 3.25% per annum for Eurodollar Loans, and 2.25% per annum for ABR Loans.

 

Notwithstanding the foregoing, in the event that the financial statements required to be delivered pursuant to Subsection 7.1(a) or 7.1(b), as applicable, and the related Compliance Certificate required to be delivered pursuant to Subsection 7.2(b), are not delivered when due, then:

 

(1)                                 if such financial statements and Compliance Certificate are delivered after the date such financial statements and Compliance Certificate were required to be delivered (without giving effect to any applicable cure period) and the Applicable Margin in respect of the Initial Term Loans increases from that previously in effect as a result of the delivery of such financial statements, then the Applicable Margin in respect of the Initial Term Loans during the period from the date upon which such financial statements were required to be delivered (without giving effect to any applicable cure period) until the date upon which they actually are delivered shall, except as otherwise provided in clause (3) below, be the Applicable Margin as so increased;

 

(2)                                 if such financial statements and Compliance Certificate are delivered after the date such financial statements and Compliance Certificate were required to be delivered and the Applicable Margin in respect of the Initial Term Loans decreases from that previously in effect as a result of the delivery of such financial statements, then such decrease in the Applicable Margin in respect of the Initial Term Loans shall not become applicable until the date upon which the financial statements and Compliance Certificate actually are delivered, and

 

(3)                                 if such financial statements and Compliance Certificate are not delivered prior to the expiration of the applicable cure period, then, effective upon such expiration, for the period from the date upon which such financial statements and Compliance Certificate were required to be delivered (after the expiration of the applicable cure period) until two Business Days following the date upon which they actually are delivered, Pricing Level 2 shall apply in respect of the Initial Term Loans (it being understood that the foregoing shall not limit the rights of the Administrative Agent and the Lenders set forth in Section 9).”

 

v.                                      by inserting the words “, Tranche B-2 Term Loan Commitments” after the words “Initial Term Loan Commitments” appearing in the definition of “Borrowing”,

 

vi.                                   by inserting the words “or Tranche B-2 Term Loan Commitment” after the words “Initial Term Loan Commitment” appearing in clause (b) of the definition of “Conduit Lender”,

 

vii.                                by amending and restating the definition of “Facility” as follows:

 

5

 

““Facility”:  each of (a) the Initial Term Loan Commitments and the Extensions of Credit made thereunder, (b) the Tranche B-2 Term Loan Commitments and the Extensions of Credit made thereunder and (c) any other committed facility hereunder and the Extensions of Credit made thereunder.”

 

viii.                             by inserting the word “applicable” immediately before the words “Maturity Date” appearing in clause (b)(ii) of the definition of “Interest Period”,

 

ix.                                   by amending and restating the definition of “Lead Arranger” as follows:

 

““Lead Arrangers”:  in respect of (I) Initial Term Loans, Deutsche Bank Securities Inc., Barclays Capital, Merrill Lynch, Pierce, Fenner & Smith Incorporated, Morgan Stanley Senior Funding, Inc., RBC Capital Markets, and UBS Securities LLC, as Joint Lead Arrangers (collectively, the “Original Lead Arrangers”) and (II) Tranche B-2 Term Loans, Barclays Bank PLC, Goldman Sachs Bank USA, Deutsche Bank Securities Inc., Merrill Lynch, Pierce, Fenner & Smith Incorporated and J.P. Morgan Securities LLC, as Joint Lead Arrangers (collectively, the “Tranche B-2 Lead Arrangers”).  For the avoidance of doubt, Tranche B-2 Lead Arrangers shall not constitute Lead Arrangers for the purposes of Subsections 6.1(b) and (e).”

 

x.                                      by amending and restating the definition of “Loan” as follows:

 

““Loan”:  each Initial Term Loan, Tranche B-2 Term Loan, Incremental Loan and/or Extended Loan, as the context shall require; collectively, the “Loans”.”

 

xi.                                   by amending and restating the definition of “Maturity Date” as follows:

 

““Maturity Date”:  in respect of (I) Initial Term Loans, May 25, 2018, and (II) Tranche B-2 Term Loans, October 28, 2022, as the context may require.”

 

xii.                                by amending and restating the definition of “Other Representatives” as follows:

 

““Other Representatives”:  in respect of (I) Initial Term Loans, each of Deutsche Bank Securities Inc., Barclays Capital, Merrill Lynch, Pierce, Fenner & Smith Inc., Morgan Stanley Senior Funding, Inc., RBC Capital Markets, and UBS Securities LLC, in their collective capacity as Joint Lead Arrangers, and Barclays Capital, Merrill Lynch, Pierce, Fenner & Smith Inc., Morgan Stanley Senior Funding, Inc., RBC Capital Markets, UBS Securities LLC, Citigroup Global Markets Inc. and Natixis, in their collective capacity as Joint Bookmanagers, and (II) Tranche B-2 Term Loans, each of Barclays Bank PLC, Goldman Sachs Bank USA, Deutsche Bank Securities Inc., Merrill Lynch, Pierce, Fenner & Smith Incorporated and J.P. Morgan Securities LLC, in their collective capacity as Joint Bookrunners, each of Barclays Bank PLC, Goldman Sachs Bank USA, Deutsche 

 

6

 

Bank Securities Inc., Merrill Lynch, Pierce, Fenner & Smith Incorporated and J.P. Morgan Securities LLC in their collective capacity as Joint Lead Arrangers, and Fifth Third Bank, UBS Securities LLC and Wells Fargo Securities, LLC, in their collective capacity as co-managers.”

 

xiii.                             by amending and restating the definition of “Term Loans” as follows:

 

““Term Loans”:  the Initial Term Loans, Tranche B-2 Term Loans, Incremental Term Loans and/or Extended Term Loans, as the context shall require.”

 

xiv.                            by amending and restating the definition of “Tranche” as follows:

 

““Tranche”:  with respect to Term Loans or commitments, refers to whether such Term Loans or commitments are (1) Initial Term Loans or Initial Term Loan Commitments, (2) Tranche B-2 Term Loans or Tranche B-2 Term Loan Commitments, (3) Incremental Loans or Incremental Commitments with the same terms and conditions made on the same day, or (4) Extended Term Loans (of the same Extension Series); provided that, the 2013 Supplemental Term Loans shall be considered part of the Initial Term Loans to which such 2013 Supplemental Term Loans are added pursuant to the definition of Initial Term Loan.”

 

(c)                                  Section 2.1 of the Credit Agreement is hereby amended as follows:

 

i.                                          by deleting the reference to “Initial Term Loans” in the section heading thereof and replacing it with “Term Loans”,

 

ii.                                       by inserting “(a)” before the beginning of the first sentence thereof and

 

iii.                                    by inserting the following as new clause (b) thereof:

 

“(b)                           Subject to the terms and conditions hereof, each Lender holding a Tranche B-2 Term Loan Commitment severally agrees to make, in Dollars, in a single draw on the Second Amendment Effective Date, one or more term loans to the Borrower in an aggregate principal amount not to exceed the amount set forth opposite such Lender’s name in Schedule A-1 under the heading “Tranche B-2 Term Loan Commitment”, as such amount may be adjusted or reduced pursuant to the terms hereof, which Tranche B-2 Term Loans:

 

(i)                                     shall, at the option of the Borrower, be incurred and maintained as and/or converted into, ABR Loans or Eurodollar Loans; and

 

(ii)                                  shall be made by each such Lender in an aggregate principal amount which does not exceed the Tranche B-2 Term Loan Commitment of such Lender.

 

7

 

Once repaid, Tranche B-2 Term Loans incurred hereunder may not be reborrowed.  On the Second Amendment Effective Date (after giving effect to the incurrence of Tranche B-2 Term Loans on such date), the Tranche B-2 Term Loan Commitment of each Tranche B-2 Term Lender shall terminate.”

 

(d)                                 Section 2.2 of the Credit Agreement is hereby amended as follows:

 

i.                                          by amending and restating clause (a) thereof as follows:

 

“The Borrower agrees that, upon the request to the Administrative Agent by any Lender made on or prior to the Closing Date (in the case of requests relating to Loans other than the Tranche B-2 Term Loans) or the Second Amendment Effective Date (in the case of requests relating to the Tranche B-2 Term Loans) or in connection with any assignment pursuant to Subsection 11.6(b), in order to evidence such Lender’s Loan, the Borrower will execute and deliver to such Lender a promissory note substantially in the form of Exhibit A (each, as amended, supplemented, replaced or otherwise modified from time to time, a “Note” and, collectively, the “Notes”), in each case with appropriate insertions therein as to payee, date and principal amount, payable to such Lender and in a principal amount equal to the unpaid principal amount of the applicable Loans made (or acquired by assignment pursuant to Subsection 11.6(b)) by such Lender to the Borrower.  Each Note in respect of an Initial Term Loan shall be dated the Closing Date.  Each Note in respect of a Tranche B-2 Term Loan shall be dated the Second Amendment Effective Date.  Each Note shall be payable as provided in Subsections 2.2(b) or 2.2(c), as applicable, and provide for the payment of interest in accordance with Subsection 4.1.”

 

ii.                                       by inserting the words “in respect of the Initial Term Loans” after the words “Maturity Date” appearing in clause (b) thereof,

 

iii.                                    by inserting the following as new clause (c) thereof:

 

“(c)                            The Tranche B-2 Term Loans of all the Lenders shall be payable in consecutive quarterly installments beginning on March 31, 2016 up to and including the Maturity Date in respect of the Tranche B-2 Term Loans (subject to reduction as provided in Subsection 4.4), on the dates and in the principal amounts, subject to adjustment as set forth below, equal to the respective amounts set forth below (together with all accrued interest thereon) opposite the applicable installment dates (or, if less, the aggregate amount of such Tranche B-2 Term Loans then outstanding):

 

8

 

	
Date
    	
 
    	
Amount
    
	
Each March 31, June 30, September 30   and December 31 ending prior to the Maturity Date in respect of the   Tranche B-2 Term Loans
    	
 
    	
0.25% of the aggregate initial principal amount of   the Tranche B-2 Term Loans on the Second Amendment Effective Date
    
	
Maturity Date in respect of the Tranche B-2 Term   Loans
    	
 
    	
all unpaid aggregate principal amounts of any   outstanding Tranche B-2 Term Loans
    

 

(e)                                  Subsection 2.3 of the Credit Agreement is hereby amended and restated as follows:

 

“Procedure for Term Loan Borrowing.  The Borrower shall have given the Administrative Agent notice (which notice must have been received by the Administrative Agent prior to 9:00 A.M., New York City time, and shall be irrevocable after funding) on (i) the Closing Date specifying the amount of the Initial Term Loans to be borrowed or (ii) the Second Amendment Effective Date specifying the amount of Tranche B-2 Term Loans to be borrowed.  Upon receipt of such notice, the Administrative Agent shall promptly notify each applicable Lender thereof.  Each applicable Lender will make (a) in the case of the Initial Term Loans, the amount of its pro rata share (based on its Initial Term Loan Percentage) of the Initial Term Loan Commitments and (b) in the case of the Tranche B-2 Term Loans, the amount of its pro rata share (based on its Tranche B-2 Term Loan Percentage) of the Tranche B-2 Term Loan Commitments, as applicable, available to the Administrative Agent, in each case for the account of the Borrower at the office of the Administrative Agent specified in Subsection 11.2 prior to 10:00 A.M., New York City time, on the Closing Date or the Second Amendment Effective Date, as applicable, in funds immediately available to the Administrative Agent.  The Administrative Agent shall on such date credit the account of the Borrower on the books of the Administrative Agent with the aggregate of the amounts made available to the Administrative Agent by the Lenders and in like funds as received by the Administrative Agent.”

 

(f)                                   Subsection 2.5 of the Credit Agreement is hereby amended as follows:

 

i.                                          by amending and restating the first sentence of clause (a) thereof as follows:

 

“The Borrower hereby unconditionally promises to pay to the Administrative Agent (in the currency in which such Term Loan is denominated) for the account of:  (i) each applicable Lender the then unpaid principal amount of each Initial Term Loan of such Lender made to the Borrower, on the Maturity Date in respect of the Initial Term Loans (or such earlier date on which the Initial Term Loans become due and payable pursuant to Section 9) and (ii) each applicable Lender the then unpaid principal amount of each Tranche B-2 Term Loan of such Lender made to the Borrower, on the Maturity Date in respect of the 

 

9

 

Tranche B-2 Term Loans (or such earlier date on which the Tranche B-2 Term Loans become due and payable pursuant to Section 9).”

 

ii.                                       by inserting the words “, the Tranche thereof” after the words “the Type thereof” appearing in clause (c) thereof.

 

(g)                                  Subsection 2.6(d) of the Credit Agreement is hereby amended by amending and restating subclause (iv) thereof as follows:

 

“(iv) the interest rate margins applicable to the loans made pursuant to the Incremental Commitments shall be determined by the Borrower and the applicable Additional Lenders; provided that in the event that the applicable interest rate margins for any term loans Incurred by the Borrower under any Incremental Term Loan Commitment (solely for the purposes of the Tranche B-2 Term Loans, to the extent that such term loans are Incurred on or prior to the 12-month anniversary of the Second Amendment Effective Date) are higher than the applicable interest rate margin for the Initial Term Loans and the Tranche B-2 Term Loans by more than 50 basis points, then the Applicable Margin for the Initial Term Loans and/or the Tranche B-2 Term Loans shall be increased to the extent necessary so that the applicable interest rate margin for the Initial Term Loans and/or the Tranche B-2 Term Loans is equal to the applicable interest rate margins for such Incremental Term Loan Commitment minus 50 basis points; provided, further that, in determining the applicable interest rate margins for the Initial Term Loans, the Tranche B-2 Term Loans and the Incremental Term Loans, (A) original issue discount (“OID”) or upfront fees payable generally to all participating Additional Lenders in lieu of OID (which shall be deemed to constitute like amounts of OID) payable by the Borrower to the Lenders under the Initial Term Loans, the Tranche B-2 Term Loans or any Incremental Term Loan in the initial primary syndication thereof shall be included (with OID being equated to interest based on an assumed four-year life to maturity); (B) any arrangement, structuring or other fees payable in connection with the Incremental Term Loans that are not shared with all Additional Lenders providing such Incremental Term Loans shall be excluded; (C) any amendments to the Applicable Margin on the Initial Term Loans or the Tranche B-2 Term Loans that became effective subsequent to the Closing Date (with respect to Initial Term Loans) or the Second Amendment Effective Date (with respect to the Tranche B-2 Term Loans) but prior to the time of such Incremental Term Loans shall also be included in such calculations and (D) if the Incremental Term Loans include an interest rate floor greater than the interest rate floor applicable to the Initial Term Loans and/or the Tranche B-2 Term Loans, such increased amount shall be equated to the applicable interest rate margin for purposes of determining whether an increase to the Applicable Margin for the Initial Term Loans and/or the Tranche B-2 Term Loans shall be required, to the extent an increase in the interest rate floor for the Initial Term Loans and/or the Tranche B-2 Term Loans would cause an increase in the interest rate then in effect thereunder, and in such case the

 

10

 

interest rate floor (but not the Applicable Margin) applicable to the Initial Term Loans and/or the Tranche B-2 Term Loans shall be increased by such amount.”

 

(h)                                 Subsection 2.8 of the Credit Agreement is hereby amended by inserting the words “, Tranche B-2 Term Loans” after the words “Initial Term Loans” in clause (a) thereof.

 

(i)                                     Subsection 4.2 of the Credit Agreement is hereby amended by inserting the word “applicable” immediately before the words “Maturity Date” appearing in clauses (a) and (b) thereof and by deleting the word “either” appearing before the words “Maturity Date” in clause (b) thereof.

 

(j)                                    Subsection 4.4 of the Credit Agreement is hereby amended as follows:

 

i.                                          by inserting the following sentence after the last sentence appearing in clause (a) thereof:

 

“Each prepayment of Tranche B-2 Term Loans pursuant to this Subsection 4.4(a) made on or prior to the six-month anniversary of the Second Amendment Effective Date in an amount equal to, or with the Net Cash Proceeds received by the Borrower or any Restricted Subsidiary from, its incurrence of new Indebtedness under first lien secured term loan bank financing in a Tranche B-2 Repricing Transaction shall be accompanied by the payment of the fee required by Subsection 4.5(c).”

 

ii.                                       by inserting the words “Tranche B-2 Term Loans,” after the words “Initial Term Loans,” in the first sentence of clause (c) thereof.

 

(k)                                 Subsection 4.5 of the Credit Agreement is hereby amended by inserting the following new clause (c) thereof:

 

“(c)                            If on or prior to the six-month anniversary of the Second Amendment Effective Date the Borrower makes an optional prepayment in full of the Tranche B-2 Term Loans in an amount equal to, or with the Net Cash Proceeds received by the Borrower or any Restricted Subsidiary from, its incurrence of new Indebtedness under first lien secured bank term loan financing in a Tranche B-2 Repricing Transaction, the Borrower shall pay to the Administrative Agent, for the ratable account of each Tranche B-2 Term Lender, a prepayment premium of 1.0% of the aggregate principal amount of Tranche B-2 Term Loans being prepaid.  If, on or prior to the six-month anniversary of the Second Amendment Effective Date, any Lender is replaced pursuant to Subsection 11.1(g) in connection with any amendment of this Agreement (including in connection with any refinancing transaction permitted under Subsection 11.6(g) to replace the Tranche B-2 Term Loans) that results in a Tranche B-2 Repricing Transaction, such Lender (and not any Person who replaces such Lender pursuant to Subsection 2.8(e) or 11.1(g)) shall receive a fee

 

11

 

equal to 1.0% of the principal amount of the Tranche B-2 Term Loans of such Lender assigned to a replacement Lender pursuant to Subsection 2.8(e) or 11.1(g).”

 

(l)                                     Subsection 5.16 is hereby amended and restated as follows:

 

“The proceeds of Term Loans shall be used by the Borrower (i) in the case of the Initial Term Loans other than the 2013 Supplemental Term Loans, to effect, in part, the Refinancing and the other Transactions, and to pay certain fees and expenses relating thereto, (ii) in the case of Tranche B-2 Term Loans, to finance the working capital, capital expenditures, business requirements, acquisitions and other general corporate purposes of the Borrower and its Restricted Subsidiaries and (iii) in the case of all other Term Loans, to finance the working capital, capital expenditures, business requirements and other general corporate purposes of the Borrower and its Restricted Subsidiaries.”

 

(m)                             Subsection 11.1(d)(ii) is hereby amended and restated as follows:

 

“(ii) in accordance with Subsection 2.6 to incorporate the terms of any Incremental Commitments (including to add a new revolving facility under this Agreement with respect to any Incremental Revolving Commitment and including the incorporation of such additional changes to the terms of the Tranche B-2 Term Loans after the Second Amendment Effective Date as are contemplated by the provisions of the Tranche B-2 Fee Letter (as in effect on the Second Amendment Effective Date) and”.

 

(n)                                 Subsection 11.2 of the Credit Agreement is hereby amended by deleting the reference to “Schedule A” in clause (a) thereof and replacing it with “Schedules A and A-1”.

 

(o)                                 Subsection 11.6 of the Credit Agreement is hereby amended as follows:

 

i.                                          by inserting the words “, Tranche B-2 Term Loan Commitments” after the words “Initial Term Loan Commitments” appearing in subclause (iv) of clause (b) thereof,

 

ii.                                       by inserting the words “, Tranche B-2 Term Loan Commitments” after the words “Incremental Commitments” appearing in the third to last paragraph of clause (b) thereof and

 

iii.                                    by inserting the words “Tranche B-2 Term Loan Commitments,” after the words “Initial Term Loan Commitments,” in the first sentence of subclause (i) of clause (c) thereof.

 

(p)                                 Exhibit N to the Credit Agreement is hereby amended by deleting each reference to “Initial Term Loans” and replacing it with “[Initial Term Loans][Tranche B-2 Term Loans]”.

 

12

 

(q)                                 Exhibit O to the Credit Agreement is hereby amended as follows:

 

i.                                          by deleting each reference to “Initial Term Loans” and replacing it with “[Initial Term Loans][Tranche B-2 Term Loans]” and

 

ii.                                       by inserting the words “[$[·] of Tranche B-2 Term Loans]” after the words “[$[·] of Initial Term Loans]” in subparagraph (2) of the second paragraph thereof.

 

(r)                                    Exhibit P to the Credit Agreement is hereby amended as follows:

 

i.                                          by deleting each reference to “Initial Term Loans” and replacing it with “[Initial Term Loans][Tranche B-2 Term Loans]” and

 

ii.                                       by inserting the words “[Tranche B-2 Term Loans - $[·]]” after the words “[Initial Term Loans - $[·]]” appearing in subparagraph (2) of the second paragraph thereof.

 

(s)                                   Exhibit Q to the Credit Agreement is hereby amended as follows:

 

i.                                          by deleting each reference to “Initial Term Loans” and replacing it with “[Initial Term Loans][Tranche B-2 Term Loans]” and

 

ii.                                       by inserting the words “[Tranche B-2 Term Loans - $[·]]” after the words “[Initial Term Loans - $[·]]” appearing in subparagraph (2) of the second paragraph thereof.

 

(t)                                    Exhibit R to the Credit Agreement is hereby amended as follows:

 

i.                                          by deleting each reference to “Initial Term Loans” and replacing it with “[Initial Term Loans][Tranche B-2 Term Loans]” and

 

ii.                                       by inserting the words “[Tranche B-2 Term Loans - $[·]]” after the words “[Initial Term Loans - $[·]]” appearing in subparagraph (2) of the second paragraph thereof.

 

(u)                                 Exhibit S to the Credit Agreement is hereby amended by deleting each reference to “Initial Term Loans” and replacing it with “[Initial Term Loans][Tranche B-2 Term Loans]”.

 

(v)                                 Exhibit T to the Credit Agreement is hereby amended as follows:

 

i.                                          by deleting each reference to “Initial Term Loans” and replacing it with “[Initial Term Loans][Tranche B-2 Term Loans]” and

 

ii.                                       by inserting the words “[Tranche B-2 Term Loans - $[·]]” after the words “[Initial Term Loans - $[·]]” appearing in the second paragraph thereof.

 

13

 

(w)                               The Schedules to the Credit Agreement are hereby amended by adding as new Schedule A-1 Annex I hereto.

 

SECTION TWO - Conditions to Effectiveness relating to Credit Agreement Amendments.  This Second Amendment relating to the Credit Agreement Amendments shall become effective on the date (the “Second Amendment Effective Date”) when each of the following conditions shall have been satisfied:

 

(a)                                 the Borrower, the Tranche B-2 Term Lenders and the Administrative Agent shall have signed a counterpart hereof (whether the same or different counterparts) and shall have delivered (including by way of facsimile or other electronic transmission) the same to White & Case LLP, 1155 Avenue of the Americas, New York, NY 10036, attention:  Alina Weiss (facsimile number:  +1 212 354 8113, email address:  alina.weiss@whitecase.com);

 

(b)                                 the Administrative Agent shall have received (A) true and complete copies of resolutions of the board of directors or a duly authorized committee thereof of the Borrower approving and authorizing the execution, delivery and performance of this Second Amendment, and the performance of the Credit Agreement as amended by this Second Amendment, certified as of the Second Amendment Effective Date by a Responsible Officer, secretary or assistant secretary of the Borrower as being in full force and effect without modification or amendment and (B) good standing certificate (or the equivalent thereof) for the Borrower from its jurisdiction of formation;

 

(c)                                  the Borrower shall have delivered to the Administrative Agent and the Lenders an opinion from each of Debevoise & Plimpton LLP, counsel to the Borrower, and the General Counsel of the Borrower, in each case, in form and substance reasonably satisfactory to the Administrative Agent and dated as of the Second Amendment Effective Date;

 

(d)                                 the Administrative Agent shall have received a certificate of the Borrower required pursuant to Subsection 2.6(a) and the definition of “Maximum Incremental Facilities Amount” in the Credit Agreement;

 

(e)                                  all fees and expenses then due and payable to the Administrative Agent, the Other Representatives in respect of the Tranche B-2 Term Loans and the Tranche B-2 Term Loan Lenders pursuant to the Tranche B-2 Fee Letter and Section Five hereof shall have been paid on, or contemporaneously with the funding of Tranche B-2 Term Loans on, the Second Amendment Effective Date;

 

(f)                                   the Administrative Agent shall have received a notice of such borrowing as required by Subsection 2.3 of the Credit Agreement (as amended hereby);

 

(g)                                  the Acquisition shall have been or, substantially concurrently with the initial borrowing under the Tranche B-2 Term Loans shall be, consummated in all material respects in accordance with the terms of the Merger Agreement, without giving effect to any modifications, amendments, express waivers or express consents thereunder by the Buyers that are materially adverse to the Tranche B-2 Lenders without the consent of the Tranche B-2 Lead

 

14

 

Arrangers and the Other Representatives (such consent not to be unreasonably withheld, conditioned or delayed), it being understood and agreed that any change in the purchase price shall not be deemed to be materially adverse to the Tranche B-2 Lenders but (x) any resulting reduction in purchase price to the extent resulting in lower cash funding by the Buyers shall be allocated to a reduction in the Tranche B-2 Term Loans and (y) any increase in purchase price (excluding, for the avoidance of doubt, purchase price adjustments pursuant to the Merger Agreement) may be funded with the Borrower’s cash, borrowings under the ABL Facility (provided, that the proceeds of the ABL Facility may not be used to fund an increase in the purchase price in excess of 10% of the purchase price and all fees, expenses and premiums related thereto) or the proceeds of a common stock or other “qualified” equity issuance or a common equity contribution received by the Borrower;

 

(h)                                 no Material Adverse Effect (as defined in the Merger Agreement) on the Target shall have occurred since the date of the Merger Agreement (other than any Material Adverse Effect under clause (i)(B) of the definition of “Material Adverse Effect” that has been cured prior to the Second Amendment Effective Date);

 

(i)                                     the Administrative Agent shall have received a certificate of the chief financial officer or treasurer (or other comparable officer) of the Borrower certifying the Solvency, after giving effect to the Acquisition, of the Borrower and its Restricted Subsidiaries on a consolidated basis in substantially the form reasonably acceptable to the Administrative Agent;

 

(j)                                    the Administrative Agent and the Tranche B-2 Lenders shall have received at least three days prior to the Second Amendment Effective Date all documentation and information reasonably requested in writing by the Administrative Agent, at least ten calendar days prior to the Second Amendment Effective Date, about the Borrower and the Guarantors mutually agreed to be required by U.S. regulatory authorities under applicable “know your customer” and anti-money laundering rules and regulations, including, without limitation, the PATRIOT Act; and

 

(k)                                 (i) the condition in Section 9.2(a) of the Merger Agreement (but only with respect to the representations that are material to the interests of the Tranche B-2 Lenders, and only to the extent that Merger Sub has the right to terminate its obligations under the Merger Agreement as a result of a breach of such representations in the Merger Agreement) shall have been satisfied and (ii) the representation and warranties in Section three below shall, except to the extent they relate to a particular date, be true and correct in all material respects on and as of such date as if made on and as of such date.

 

The making of the Tranche B-2 Term Loans by the Tranche B-2 Term Lenders hereunder shall conclusively be deemed to constitute an acknowledgement by each Tranche B-2 Term Lender that has made its respective Tranche B-2 Term Loan that each of the conditions precedent set forth in Section Two of this Second Amendment and the Credit Agreement shall have been satisfied in accordance with its respective terms or shall have been irrevocably waived by such Person.

 

15

 

SECTION THREE - Representations and Warranties; No Default.  In order to induce the Tranche B-2 Lenders party hereto and the Administrative Agent to enter into this Second Amendment, the Borrower represents and warrants to each of such Lenders and the Administrative Agent that on and as of the date hereof after giving effect to this Second Amendment, (i) no Default or Event of Default exists as of the Second Amendment Effective Date; (ii) the representations and warranties of each Loan Party contained in Section 5 of the Credit Agreement and in the other Loan Documents are true and correct in all material respects on and as of the date hereof except to the extent that such representations and warranties relate to an earlier date, in which case such representations and warranties shall be true and correct in all material respects as of such earlier date; (iii) the execution, delivery and performance of this Second Amendment has been duly authorized by all necessary corporate action on the part of the Borrower, has been duly executed and delivered by the Borrower and constitutes a legal, valid and binding obligation of the Borrower, enforceable against the Borrower in accordance with its terms, except to the extent that the enforceability hereof may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or other similar laws affecting creditors’ rights generally and subject to general principles of equity, regardless of whether considered in a proceeding in equity or at law; and (iv) the execution and delivery hereof by the Borrower and the performance and observance by the Borrower of the provisions hereof do not violate or conflict with (A) any Organizational Document of the Borrower or (B) any Requirement of Law applicable to the Borrower or result in a breach of any provision of any Contractual Obligation of the Borrower, in each case, in any respect that would reasonably be expected to have a Material Adverse Effect.

 

SECTION FOUR - Covenants.

 

(a)                                 The Borrower shall have obtained a release of all liens and mortgages (other than Permitted Liens) on the assets of the Target and its Subsidiaries within 90 days of the Second Amendment Effective Date (or such other period as may be reasonably agreed by the Administrative Agent in its sole discretion).

 

(b)                                 The Borrower shall have within 90 days of the Second Amendment Effective Date (or such other period as may be agreed by the Administrative Agent in its sole discretion) satisfied the requirements set forth in Section 7.9 of the Credit Agreement with respect to the Target and its Subsidiaries (it being understood and agreed that this Second Amendment shall constitute a request of the Administrative Agent to satisfy the requirements under Section 7.9).

 

(c)                                  The parties hereto shall enter into all amendments to the Credit Agreement that are necessary after the Second Amendment Effective Date to implement the provisions of the Tranche B-2 Fee Letter (as in effect on the Second Amendment Effective Date) as contemplated by clause (m) of Section One of the Second Amendment.

 

SECTION FIVE - Fees.

 

(a)                                 The Administrative Agent shall have received, for the account of the Tranche B-2 Lenders, an upfront fee in an amount equal to 0.50% of the sum of the aggregate

 

16

 

principal amount of the Tranche B-2 Term Loans, which upfront fee may be structured as original issue discount at the option of the Lead Arrangers in respect of the Tranche B-2 Term Loans.

 

(b)                                 The Borrower agrees to reimburse the Administrative Agent and the Other Representatives in respect of the Tranche B-2 Term Loans for their reasonable and documented out-of-pocket expenses incurred by them in connection with this Second Amendment, including the reasonable fees, charges and disbursements of Cahill Gordon & Reindel LLP, counsel for the Other Representatives in respect of the Tranche B-2 Term Loans, and White & Case LLP, counsel for the Administrative Agent, (I) in the case of the Administrative Agent in accordance with Subsection 11.5 of the Credit Agreement and (II) in the case of the Other Representatives in accordance with the Commitment Letter dated as of July 30, 2015, as amended, by and among the Borrower and other parties thereto.

 

SECTION SIX - Reference to and Effect on the Credit Agreement and the Notes.  On and after the effectiveness of this Second Amendment, each reference in the Credit Agreement to “this Agreement”, “hereunder”, “hereof” or words of like import referring to the Credit Agreement, and each reference in the Notes and each of the other Loan Documents to “the Credit Agreement”, “thereunder”, “thereof” or words of like import referring to the Credit Agreement, shall mean and be a reference to the Credit Agreement, as amended by this Second Amendment.  The Credit Agreement, the Notes and each of the other Loan Documents, as specifically amended by this Second Amendment, are and shall continue to be in full force and effect and are hereby in all respects ratified and confirmed.  The execution, delivery and effectiveness of this Second Amendment shall not, except as expressly provided herein, operate as an amendment or waiver of any right, power or remedy of any Lender or any Agent under any of the Loan Documents, nor constitute an amendment or waiver of any provision of any of the Loan Documents.  The Borrower hereby expressly acknowledges the terms of this Second Amendment and reaffirms, as of the date hereof, (i) the covenants and agreements contained in each Loan Document to which it is a party, including, in each case, such covenants and agreements as in effect immediately after giving effect to this Second Amendment and the transactions contemplated hereby and (ii) its grant of Liens on the Collateral to secure the Secured Obligations (including, without limitation, in respect of the Tranche B-2 Term Loans) pursuant to the Security Documents.

 

SECTION SEVEN - Execution in Counterparts.  This Second Amendment may be executed in counterparts (and by different parties hereto on different counterparts), each of which shall constitute an original, but all of which, when taken together, shall constitute a single contract.  Delivery of an executed counterpart of this Second Amendment by facsimile transmission or electronic photocopy (i.e., “pdf”) shall be effective as delivery of a manually executed counterpart of this Second Amendment.

 

SECTION EIGHT - Governing Law.  THIS AMENDMENT AND THE RIGHTS AND OBLIGATIONS OF THE PARTIES UNDER THIS SECOND AMENDMENT SHALL BE GOVERNED BY, AND CONSTRUED AND INTERPRETED IN ACCORDANCE WITH, THE LAW OF THE STATE OF NEW YORK, WITHOUT GIVING EFFECT TO ITS PRINCIPLES OR RULES OF CONFLICT OF LAWS TO THE EXTENT SUCH PRINCIPLES

 

17

 

OR RULES ARE NOT MANDATORILY APPLICABLE BY STATUTE AND WOULD REQUIRE OR PERMIT THE APPLICATION OF THE LAWS OF ANOTHER JURISDICTION.

 

18

 

IN WITNESS WHEREOF, the parties hereto have caused this Second Amendment to be duly executed and delivered as of the day and year first above written.

 

	
 
    	
ENVISION HEALTHCARE   CORPORATION
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
By: 
    	
/s/ Randel G. Owen
    
	
 
    	
Name:
    	
Randel G. Owen
    
	
 
    	
Title:
    	
Chief Financial Officer
    

 

[Signature Page to Second Amendment to Term Loan Credit Agreement]

 

 

	
 
    	
DEUTSCHE BANK AG NEW   YORK BRANCH,
    
	
 
    	
as Administrative Agent   and Collateral Agent
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
By: 
    	
/s/ Michael Winters
    
	
 
    	
Name:
    	
Michael Winters
    
	
 
    	
Title:
    	
Vice President
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
By: 
    	
/s/ Peter Cucchiara
    
	
 
    	
Name:
    	
Peter Cucchiara
    
	
 
    	
Title:
    	
Vice President
    

 

[Signature Page to Second Amendment to Term Loan Credit Agreement]

 

 

	
 
    	
BARCLAYS BANK PLC,
    
	
 
    	
as Tranche B-2 Term   Loan Lender
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
By:
    	
/s/ Ritam Bhalla
    
	
 
    	
Name:
    	
Ritam Bhalla
    
	
 
    	
Title:
    	
Director
    

 

[Signature Page to Second Amendment to Term Loan Credit Agreement]

 

 

	
 
    	
GOLDMAN SACHS BANK USA,
    
	
 
    	
as Tranche B-2 Term   Loan Lender
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
By:
    	
/s/ Charles D. Johnston
    
	
 
    	
Name:
    	
Charles D. Johnston
    
	
 
    	
Title:
    	
Authorized Signatory
    

 

[Signature Page to Second Amendment to Term Loan Credit Agreement]

 

 

	
 
    	
BANK OF AMERICA, N.A.,
    
	
 
    	
as Tranche B-2 Term   Loan Lender
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
By:
    	
/s/ Matt Lynn
    
	
 
    	
Name:
    	
Matt Lynn
    
	
 
    	
Title:
    	
Managing Director
    

 

[Signature Page to Second Amendment to Term Loan Credit Agreement]

 

 

	
 
    	
DEUTSCHE BANK AG NEW YORK BRANCH,
    
	
 
    	
as Tranche B-2 Term   Loan Lender
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
By:
    	
/s/ Michael Winters
    
	
 
    	
Name:
    	
Michael Winters
    
	
 
    	
Title:
    	
Vice President
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
By:
    	
/s/ Peter Cucchiara
    
	
 
    	
Name:
    	
Peter Cucchiara
    
	
 
    	
Title:
    	
Vice President
    

 

[Signature Page to Second Amendment to Term Loan Credit Agreement]

 

 

	
 
    	
JPMORGAN CHASE BANK,   N.A.,
    
	
 
    	
as Tranche B-2 Term   Loan Lender
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
By:
    	
/s/ Vanessa Chiu
    
	
 
    	
Name:
    	
Vanessa Chiu
    
	
 
    	
Title:
    	
Executive Director
    

 

[Signature Page to Second Amendment to Term Loan Credit Agreement]

 

 

	
 
    	
WELLS FARGO BANK,   NATIONAL ASSOCIATION,
    
	
 
    	
as Tranche B-2 Term   Loan Lender
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
By:
    	
/s/ Jessica DeLorm
    
	
 
    	
Name:
    	
Jessica DeLorm
    
	
 
    	
Title:
    	
Duly Authorized   Signatory
    

 

[Signature Page to Second Amendment to Term Loan Credit Agreement]

 

 

	
 
    	
FIFTH THIRD BANK,
    
	
 
    	
as Tranche B-2 Term   Loan Lender
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/ Nathaniel E. Sher
    
	
 
    	
Nathaniel E. Sher
    
	
 
    	
Vice President
    

 

[Signature Page to Second Amendment to Term Loan Credit Agreement]

 

 

	
 
    	
UBS AG, STAMFORD   BRANCH,
    
	
 
    	
as Tranche B-2 Term   Loan Lender
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/ Darlene Arias
    
	
 
    	
Name:
    	
Darlene Arias
    
	
 
    	
Title:
    	
Director
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/ Houssem Daly
    
	
 
    	
Name:
    	
Houssem Daly
    
	
 
    	
Title:
    	
Associate Director
    

 

[Signature Page to Second Amendment to Term Loan Credit Agreement]

 

 

Each Guarantor acknowledges and consents to each of the foregoing provisions of this Second Amendment and the incurrence of the Tranche B-2 Term Loans.  Each Guarantor further acknowledges and agrees that all Obligations with respect to the Tranche B-2 Term Loans shall be fully guaranteed and secured pursuant to the Guarantee and Collateral Agreement in accordance with the terms and provisions thereof.  Each Guarantor hereby agrees to the amendments contemplated by Section Two hereof.

 

 

	
 
    	
GUARANTORS:
    
	
 
    	
 
    
	
 
    	
ENVISION HEALTHCARE   INTERMEDIATE
   CORPORATION
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/ William A. Sanger
    
	
 
    	
Name:
    	
William A. Sanger
    
	
 
    	
Title:
    	
Chief Executive Officer
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
CLINICAL PARTNERS   MANAGEMENT COMPANY, LLC
    
	
 
    	
NORTHWOOD ANESTHESIA   ASSOCIATES, L.L.C.
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/ William A. Sanger
    
	
 
    	
Name:
    	
William A. Sanger
    
	
 
    	
Title:
    	
Chief Executive Officer
    

 

[Signature Page to Second Amendment to Term Loan Credit Agreement]

 

 

	
 
    	
GUARANTORS   (cont’d):
    
	
 
    	
 
    
	
 
    	
A1   LEASING, INC.
    
	
 
    	
ABBOTT   AMBULANCE, INC.
    
	
 
    	
ACCENT   HOME HEALTH CARE, INC.
    
	
 
    	
ADAM   TRANSPORTATION SERVICE, INC.
    
	
 
    	
AFFILION, INC.
    
	
 
    	
AIR   AMBULANCE SPECIALISTS, INC.
    
	
 
    	
AMBULANCE   ACQUISITION, INC.
    
	
 
    	
AMERICAN   EMERGENCY PHYSICIANS MANAGEMENT, INC.
    
	
 
    	
AMERICAN   INVESTMENT ENTERPRISES, INC.
    
	
 
    	
AMERICAN   MEDICAL PATHWAYS, INC.
    
	
 
    	
AMERICAN   MEDICAL RESPONSE AMBULANCE SERVICE, INC.
    
	
 
    	
AMERICAN   MEDICAL RESPONSE HOLDINGS, INC.
    
	
 
    	
AMERICAN   MEDICAL RESPONSE MANAGEMENT, INC.
    
	
 
    	
AMERICAN   MEDICAL RESPONSE MID-ATLANTIC, INC.
    
	
 
    	
AMERICAN   MEDICAL RESPONSE NORTHWEST, INC.
    
	
 
    	
AMERICAN   MEDICAL RESPONSE OF COLORADO, INC.
    
	
 
    	
AMERICAN   MEDICAL RESPONSE OF CONNECTICUT, INCORPORATED
    
	
 
    	
AMERICAN   MEDICAL RESPONSE OF GEORGIA, INC.
    
	
 
    	
AMERICAN   MEDICAL RESPONSE OF ILLINOIS, INC.
    
	
 
    	
AMERICAN   MEDICAL RESPONSE OF INLAND EMPIRE
    
	
 
    	
AMERICAN   MEDICAL RESPONSE OF MASSACHUSETTS, INC.
    
	
 
    	
AMERICAN   MEDICAL RESPONSE OF NORTH CAROLINA, INC.
    
	
 
    	
AMERICAN   MEDICAL RESPONSE OF OKLAHOMA, INC.
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/ Craig A. Wilson
    
	
 
    	
Name:
    	
Craig A. Wilson
    
	
 
    	
Title:
    	
Secretary
    

 

[Signature Page to Second Amendment to Term Loan Credit Agreement]

 

 

	
 
    	
GUARANTORS   (cont’d):
    
	
 
    	
 
    
	
 
    	
AMERICAN   MEDICAL RESPONSE OF SOUTH CAROLINA, INC.
    
	
 
    	
AMERICAN   MEDICAL RESPONSE OF SOUTHERN CALIFORNIA
    
	
 
    	
AMERICAN   MEDICAL RESPONSE OF TENNESSEE, INC.
    
	
 
    	
AMERICAN   MEDICAL RESPONSE OF TEXAS, INC.
    
	
 
    	
AMERICAN   MEDICAL RESPONSE WEST
    
	
 
    	
AMERICAN   MEDICAL RESPONSE, INC.
    
	
 
    	
AMR   HOLDCO, INC.
    
	
 
    	
APH   LABORATORY SERVICES, INC.
    
	
 
    	
ASSOCIATED   AMBULANCE SERVICE, INC.
    
	
 
    	
ATLANTIC   AMBULANCE SERVICES ACQUISITION, INC.
    
	
 
    	
ATLANTIC/KEY   WEST AMBULANCE, INC.
    
	
 
    	
ATLANTIC/PALM   BEACH AMBULANCE, INC.
    
	
 
    	
BESTPRACTICES, INC.
    
	
 
    	
BLYTHE   AMBULANCE SERVICE
    
	
 
    	
BROWARD   AMBULANCE, INC.
    
	
 
    	
DESERT   VALLEY MEDICAL TRANSPORT, INC.
    
	
 
    	
EHR   MANAGEMENT CO.
    
	
 
    	
EMCARE   ANESTHESIA PROVIDERS, INC.
    
	
 
    	
EMCARE   HOLDCO, INC.
    
	
 
    	
EMCARE   HOLDINGS INC.
    
	
 
    	
EMCARE   OF CALIFORNIA, INC.
    
	
 
    	
EMCARE   PHYSICIAN PROVIDERS, INC.
    
	
 
    	
EMCARE   PHYSICIAN SERVICES, INC.
    
	
 
    	
EMCARE, INC.
    
	
 
    	
EMERGENCY   MEDICAL SERVICES LP CORPORATION
    
	
 
    	
EMERGENCY   MEDICINE EDUCATION SYSTEMS, INC.
    
	
 
    	
EVERGREEN   EMERGENCY SERVICES OF ALLENTOWN, INC.
    
	
 
    	
FIVE   COUNTIES AMBULANCE SERVICE, INC.
    
	
 
    	
FLORIDA   EMERGENCY PARTNERS, INC.
    
	
 
    	
FOUNTAIN   AMBULANCE SERVICE, INC.
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/ Craig A. Wilson
    
	
 
    	
Name:
    	
Craig A. Wilson
    
	
 
    	
Title:
    	
Secretary
    

 

[Signature Page to Second Amendment to Term Loan Credit Agreement]

 

 

	
 
    	
GUARANTORS   (cont’d):
    
	
 
    	
 
    
	
 
    	
GOLD   COAST AMBULANCE SERVICE
    
	
 
    	
GREATER   PINELLAS TRANSPORTATION MANAGEMENT SERVICES, INC.
    
	
 
    	
GUARDIAN   HEALTH CARE, INC.
    
	
 
    	
GUARDIAN   HEALTHCARE GROUP, INC.
    
	
 
    	
GUARDIAN   HEALTHCARE HOLDINGS, INC.
    
	
 
    	
HANK’S   ACQUISITION CORP.
    
	
 
    	
HEALTH   PRIORITY HOME CARE, INC.
    
	
 
    	
HEALTHCARE   ADMINISTRATIVE SERVICES, INC.
    
	
 
    	
HEMET   VALLEY AMBULANCE SERVICE, INC.
    
	
 
    	
HERREN   ENTERPRISES, INC.
    
	
 
    	
HOLIDAY   ACQUISITION COMPANY, INC.
    
	
 
    	
INTERNATIONAL   LIFE SUPPORT, INC.
    
	
 
    	
JLM   HEALTHCARE, INC.
    
	
 
    	
KMAC, INC.
    
	
 
    	
KUTZ   AMBULANCE SERVICE, INC.
    
	
 
    	
LIFE   LINE AMBULANCE SERVICE, INC.
    
	
 
    	
LIFECARE   AMBULANCE SERVICE, INC.
    
	
 
    	
LIFEFLEET   SOUTHEAST, INC.
    
	
 
    	
MEDEVAC   MEDICAL RESPONSE, INC.
    
	
 
    	
MEDEVAC   MIDAMERICA, INC.
    
	
 
    	
MEDIC   ONE AMBULANCE SERVICES, INC.
    
	
 
    	
MEDIC   ONE OF COBB, INC.
    
	
 
    	
MEDI-CAR   AMBULANCE SERVICE, INC.
    
	
 
    	
MEDI-CAR   SYSTEMS, INC.
    
	
 
    	
MEDICS   AMBULANCE SERVICE (DADE), INC.
    
	
 
    	
MEDICS   AMBULANCE SERVICE, INC.
    
	
 
    	
MEDICS   AMBULANCE, INC.
    
	
 
    	
MEDICS   EMERGENCY SERVICES OF PALM BEACH COUNTY, INC.
    
	
 
    	
MEDICS   SUBSCRIPTION SERVICES, INC.
    
	
 
    	
MEDICS   TRANSPORT SERVICES, INC.
    
	
 
    	
MEDICWEST   AMBULANCE, INC.
    
	
 
    	
MEDICWEST   HOLDINGS, INC.
    
	
 
    	
MEDLIFE   EMERGENCY MEDICAL SERVICE, INC.
    
	
 
    	
MEDSTAT   EMS, INC.
    
	
 
    	
MERCY   AMBULANCE OF EVANSVILLE, INC.
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/ Craig A. Wilson
    
	
 
    	
Name:
    	
Craig A. Wilson
    
	
 
    	
Title:
    	
Secretary
    

 

[Signature Page to Second Amendment to Term Loan Credit Agreement]

 

 

	
 
    	
GUARANTORS   (cont’d):
    
	
 
    	
 
    
	
 
    	
MERCY LIFE CARE
    
	
 
    	
MERCY, INC.
    
	
 
    	
METRO AMBULANCE SERVICE (RURAL), INC.
    
	
 
    	
METRO AMBULANCE SERVICE, INC.
    
	
 
    	
METRO AMBULANCE SERVICES, INC.
    
	
 
    	
METROPOLITAN AMBULANCE SERVICE
    
	
 
    	
MIDWEST AMBULANCE   MANAGEMENT COMPANY
    
	
 
    	
MOBILE MEDIC AMBULANCE   SERVICE, INC.
    
	
 
    	
NEVADA RED ROCK   AMBULANCE, INC.
    
	
 
    	
NEVADA RED ROCK   HOLDINGS, INC.
    
	
 
    	
OHERBST, INC.
    
	
 
    	
PARAMED, INC.
    
	
 
    	
PARK AMBULANCE SERVICE   INC.
    
	
 
    	
PHYSICIAN ACCOUNT MANAGEMENT, INC.
    
	
 
    	
PHYSICIANS &   SURGEONS AMBULANCE SERVICE, INC.
    
	
 
    	
PROVIDER ACCOUNT   MANAGEMENT, INC.
    
	
 
    	
PUCKETT AMBULANCE   SERVICE, INC.
    
	
 
    	
RADIOLOGY STAFFING   SOLUTIONS, INC.
    
	
 
    	
RADSTAFFING MANAGEMENT   SOLUTIONS, INC.
    
	
 
    	
RANDLE EASTERN   AMBULANCE SERVICE, INC.
    
	
 
    	
REIMBURSEMENT   TECHNOLOGIES, INC.
    
	
 
    	
RIVER MEDICAL   INCORPORATED
    
	
 
    	
S. FISHER & S.   THOMAS INC.
    
	
 
    	
SEMINOLE COUNTY   AMBULANCE, INC.
    
	
 
    	
SPRINGS AMBULANCE   SERVICE, INC.
    
	
 
    	
STAT   HEALTHCARE, INC.
    
	
 
    	
SUNRISE HANDICAP   TRANSPORT CORP.
    
	
 
    	
T.M.S. MANAGEMENT GROUP   INC.
    
	
 
    	
TEK AMBULANCE, INC.
    
	
 
    	
TIDEWATER AMBULANCE   SERVICE, INC.
    
	
 
    	
TKG, INC.
    
	
 
    	
TRANSPORTATION   MANAGEMENT SERVICES OF BREVARD, INC.
    
	
 
    	
TROUP COUNTY EMERGENCY   MEDICAL SERVICES, INC.
    
	
 
    	
VELITA SMITH HOME   HEALTH, INC.
    
	
 
    	
V.I.P. PROFESSIONAL SERVICES, INC.
    
	
 
    	
VISTA STAFFING SOLUTIONS, INC.
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By: 
    	
/s/ Craig A. Wilson
    
	
 
    	
Name: 
    	
Craig A. Wilson
    
	
 
    	
Title:
    	
Secretary
    

 

[Signature Page to Second Amendment to Term Loan Credit Agreement]

 

 

	
 
    	
GUARANTORS   (cont’d):
    
	
 
    	
 
    
	
 
    	
ACCESS 2 CARE, LLC
    
	
 
    	
 
    
	
 
    	
 
    	
By: MISSION CARE SERVICES,   LLC, as Manager of Access 2 Care, LLC
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
By: AMERICAN MEDICAL   RESPONSE, INC., as Manager of Mission Care Services, LLC
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
By: 
    	
/s/ Craig A. Wilson
    
	
 
    	
 
    	
Name: 
    	
Craig A. Wilson
    
	
 
    	
 
    	
Title:
    	
Secretary
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
ACUTE MANAGEMENT, LLC
    
	
 
    	
 
    
	
 
    	
 
    	
By: HAWKEYE HOLDCO LLC,   as Sole Member of Acute Management, LLC
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
By: 
    	
/s/ Craig A. Wilson
    
	
 
    	
 
    	
Name: 
    	
Craig A. Wilson
    
	
 
    	
 
    	
Title:
    	
Secretary
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
AGAPE HEALTH CARE   AGENCY, LLC.
    
	
 
    	
CARE CONNECTION OF   CINCINNATI LLC
    
	
 
    	
GEM CITY HOME CARE, LLC
    
	
 
    	
GUARDIAN OHIO NEWCO,   LLC
    
	
 
    	
 
    
	
 
    	
 
    	
By: GUARDIAN HEALTHCARE   HOLDINGS, INC., as Sole Member of Agape Health Care Agency, LLC, Care   Connection of Cincinnati LLC, Gem City Home Care, LLC and Guardian Ohio   NewCo, LLC
    
	
 
    	
 
    
	
 
    	
 
    	
By: 
    	
/s/ Craig A. Wilson
    
	
 
    	
 
    	
Name: 
    	
Craig A. Wilson
    
	
 
    	
 
    	
Title:
    	
Secretary
    
						

 

[Signature Page to Second Amendment to Term Loan Credit Agreement]

 

 

	
 
    	
GUARANTORS   (cont’d):
    
	
 
    	
 
    
	
 
    	
ALPHA PHYSICIAN   RESOURCES, L.L.C.
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
By: 
    	
/s/ Craig A. Wilson
    
	
 
    	
 
    	
Name: 
    	
Craig A. Wilson
    
	
 
    	
 
    	
Title:
    	
Secretary
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
AMERICAN   MEDICAL RESPONSE DELAWARE VALLEY, LLC
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
 
    	
By: 
    	
/s/ Craig A. Wilson
    
	
 
    	
 
    	
Name: 
    	
Craig A. Wilson
    
	
 
    	
 
    	
Title:
    	
Secretary
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
AMERICAN MEDICAL   RESPONSE HPPP, LLC
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
 
    	
By: AMERICAN MEDICAL   RESPONSE, INC., as Sole Member of American Medical Response HPPP, LLC
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
 
    	
By: 
    	
/s/ Craig A. Wilson
    
	
 
    	
 
    	
Name: 
    	
Craig A. Wilson
    
	
 
    	
 
    	
Title:
    	
Secretary
    
	
 
    	
 
    
	
 
    	
AMERICAN MEDICAL   RESPONSE OF MARICOPA, LLC
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
 
    	
By:
    	
/s/ Craig A. Wilson
    
	
 
    	
 
    	
Name: 
    	
Craig A. Wilson
    
	
 
    	
 
    	
Title:
    	
Secretary
    
	
 
    	
 
    	
 
    
	
 
    	
AMERICAN MEDICAL   RESPONSE OF PIMA, LLC
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
 
    	
By: 
    	
/s/ Craig A. Wilson
    
	
 
    	
 
    	
Name: 
    	
Craig A. Wilson
    
	
 
    	
 
    	
Title:
    	
Secretary
    
						

 

[Signature Page to Second Amendment to Term Loan Credit Agreement]

 

 

	
 
    	
GUARANTORS   (cont’d):
    
	
 
    	
 
    
	
 
    	
AMR BROCKTON, L.L.C.
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
By: 
    	
/s/ Craig A. Wilson
    
	
 
    	
 
    	
Name: 
    	
Craig A. Wilson
    
	
 
    	
 
    	
Title:
    	
Secretary
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
APEX ACQUISITION LLC
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
 
    	
By: 
    	
/s/ Craig A. Wilson
    
	
 
    	
 
    	
Name: 
    	
Craig A. Wilson
    
	
 
    	
 
    	
Title:
    	
Secretary
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
ARKANSAS RIVER   EMERGENCY SERVICES, LLC
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
 
    	
By: PHOENIX EMERGENCY   PHYSICIANS OF THE NORTHEAST, LLC, as Sole Member of Arkansas River Emergency   Services, LLC
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
By: PHOENIX PHYSICIANS,   LLC, as Sole Member of Phoenix Emergency Physicians of the Northeast, LLC
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
By: EMCARE, INC.,   as Sole Member of Phoenix Physicians, LLC
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
 
    	
By: 
    	
/s/ Craig A. Wilson
    
	
 
    	
 
    	
Name: 
    	
Craig A. Wilson
    
	
 
    	
 
    	
Title:
    	
Secretary
    

 

[Signature Page to Second Amendment to Term Loan Credit Agreement]

 

 

	
 
    	
GUARANTORS   (cont’d):
    
	
 
    	
 
    
	
 
    	
BRAVO REIMBURSEMENT   SPECIALIST, L.L.C.
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
By: 
    	
/s/ Craig A. Wilson
    
	
 
    	
 
    	
Name: 
    	
Craig A. Wilson
    
	
 
    	
 
    	
Title:
    	
Secretary
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
CMORX, LLC
    
	
 
    	
 
    
	
 
    	
 
    	
By:  EMCARE, INC., as Sole Member of CMORx,   LLC
    
	
 
    	
 
    
	
 
    	
 
    	
By: 
    	
/s/ Craig A. Wilson
    
	
 
    	
 
    	
Name: 
    	
Craig A. Wilson
    
	
 
    	
 
    	
Title:
    	
Secretary
    

 

[Signature Page to Second Amendment to Term Loan Credit Agreement]

 

 

	
 
    	
GUARANTORS   (cont’d):
    
	
 
    	
 
    
	
 
    	
DAN   RIVER EMERGENCY SERVICES, LLC
    
	
 
    	
EMERGENCY   SERVICES OF CENTRAL OHIO, LLC
    
	
 
    	
PHOENIX   EMERGENCY MEDICINE OF BROWARD, LLC
    
	
 
    	
PHOENIX   EMERGENCY PHYSICIANS OF THE MIDWEST, LLC
    
	
 
    	
PHOENIX   EMERGENCY PHYSICIANS OF THE NORTHEAST, LLC
    
	
 
    	
PHOENIX   EMERGENCY PHYSICIANS OF THE SOUTHEAST, LLC
    
	
 
    	
PHOENIX   EMERGENCY SERVICES OF INVERNESS, LLC
    
	
 
    	
PHOENIX   EMERGENCY SERVICES OF LEESBURG, LLC
    
	
 
    	
PHOENIX   OBSTETRICS/GYNECOLOGY, LLC
    
	
 
    	
PHOENIX   PEDIATRICS OF BROWARD, LLC
    
	
 
    	
 
    
	
 
    	
 
    	
By: PHOENIX PHYSICIANS,   LLC, as Sole Member of Dan River Emergency Services, LLC, Emergency 
   Services of Central Ohio, LLC, Phoenix Emergency
   Medicine of Broward, LLC, Phoenix Emergency Physicians of the Midwest, LLC,   Phoenix Emergency
   Physicians of the Northeast, LLC, Phoenix Emergency
   Physicians of the Southeast, LLC, Phoenix Emergency
   Services of Inverness, LLC, Phoenix Emergency
   Services of Leesburg, LLC, Phoenix
   Obstetrics/Gynecology, LLC and Phoenix Pediatrics of Broward, LLC
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
By: EMCARE, INC.,   as Sole Member of Phoenix Physicians, LLC
    
	
 
    	
 
    
	
 
    	
 
    	
By: 
    	
/s/ Craig A. Wilson
    
	
 
    	
 
    	
Name: 
    	
Craig A. Wilson
    
	
 
    	
 
    	
Title:
    	
Secretary
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
ED SOLUTIONS, LLC
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
 
    	
By: 
    	
/s/ Craig A. Wilson
    
	
 
    	
 
    	
Name: 
    	
Craig A. Wilson
    
	
 
    	
 
    	
Title:
    	
Secretary
    

 

[Signature Page to Second Amendment to Term Loan Credit Agreement]

 

 

	
 
    	
GUARANTORS   (cont’d):
    
	
 
    	
 
    
	
 
    	
EDIMS, L.L.C.
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
By: 
    	
/s/ Craig A. Wilson
    
	
 
    	
 
    	
Name: 
    	
Craig A. Wilson
    
	
 
    	
 
    	
Title:
    	
Secretary
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
EMS MANAGEMENT LLC
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
 
    	
By: 
    	
/s/ Craig A. Wilson
    
	
 
    	
 
    	
Name: 
    	
Craig A. Wilson
    
	
 
    	
 
    	
Title:
    	
Secretary
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
EMS OFFSHORE MEDICAL   SERVICES, LLC
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
 
    	
By: 
    	
/s/ Craig A. Wilson
    
	
 
    	
 
    	
Name: 
    	
Craig A. Wilson
    
	
 
    	
 
    	
Title:
    	
Secretary
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
EMSC SERVICESCO, LLC
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
 
    	
By:
    	
/s/ Craig A. Wilson
    
	
 
    	
 
    	
Name: 
    	
Craig A. Wilson
    
	
 
    	
 
    	
Title:
    	
Secretary
    
	
 
    	
 
    	
 
    
	
 
    	
 
    
	
 
    	
EVERRAD, LLC
    
	
 
    	
 
    
	
 
    	
 
    	
By:  TEMPLETON READINGS, LLC, as Sole Member of   EverRad, LLC
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
By:  EMCARE, INC., as Sole Member of   Templeton Readings, LLC
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
By: 
    	
/s/ Craig A. Wilson
    
	
 
    	
 
    	
Name: 
    	
Craig A. Wilson
    
	
 
    	
 
    	
Title:
    	
Secretary
    

 

[Signature Page to Second Amendment to Term Loan Credit Agreement]

 

 

	
 
    	
GUARANTORS   (cont’d):
    
	
 
    	
 
    
	
 
    	
EVOLUTION HEALTH LLC
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
By: 
    	
/s/ Craig A. Wilson
    
	
 
    	
 
    	
Name: 
    	
Craig A. Wilson
    
	
 
    	
 
    	
Title:
    	
Secretary
    
	
 
    	
 
    
	
 
    	
EVOLUTION MOBILE   IMAGING, LLC
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
By: 
    	
/s/ Craig A. Wilson
    
	
 
    	
 
    	
Name: 
    	
Craig A. Wilson
    
	
 
    	
 
    	
Title:
    	
Secretary
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
HAWKEYE HOLDCO LLC
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
By: 
    	
/s/ Craig A. Wilson
    
	
 
    	
 
    	
Name: 
    	
Craig A. Wilson
    
	
 
    	
 
    	
Title:
    	
Secretary
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
MEDASSOCIATES, LLC
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
By: EMCARE, INC.,   as Sole Member of
   MedAssociates, LLC
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
By: 
    	
/s/ Craig A. Wilson
    
	
 
    	
 
    	
Name: 
    	
Craig A. Wilson
    
	
 
    	
 
    	
Title:
    	
Secretary
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
MISSION CARE OF   ILLINOIS, LLC
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
By: MISSION CARE   SERVICES, LLC, as Manager of Mission Care of Illinois, LLC
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
By: AMERICAN MEDICAL RESPONSE, INC.,   as Manager of Mission Care Services, LLC
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
By: 
    	
/s/ Craig A. Wilson
    
	
 
    	
 
    	
Name: 
    	
Craig A. Wilson
    
	
 
    	
 
    	
Title:
    	
Secretary
    

 

[Signature Page to Second Amendment to Term Loan Credit Agreement]

 

 

	
 
    	
GUARANTORS   (cont’d):
    
	
 
    	
 
    
	
 
    	
MISSION CARE OF   MISSOURI, LLC
    
	
 
    	
 
    
	
 
    	
 
    	
By: MISSION CARE   SERVICES, LLC, as Manager of Mission Care of Missouri, LLC
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
By: AMERICAN MEDICAL   RESPONSE, INC., as Manager of Mission Care Services, LLC
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
By:
    	
 /s/ Craig A. Wilson
    
	
 
    	
 
    	
Name: 
    	
Craig A. Wilson
    
	
 
    	
 
    	
Title:
    	
Secretary
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
MISSION CARE SERVICES,   LLC
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
By: AMERICAN MEDICAL   RESPONSE, INC., as Manager of Mission Care Services, LLC
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
By: 
    	
/s/ Craig A. Wilson
    
	
 
    	
 
    	
Name: 
    	
Craig A. Wilson
    
	
 
    	
 
    	
Title:
    	
Secretary
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
MSO NEWCO, LLC
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
By: 
    	
/s/ Craig A. Wilson
    
	
 
    	
 
    	
Name: 
    	
Craig A. Wilson
    
	
 
    	
 
    	
Title:
    	
Secretary
    

 

[Signature Page to Second Amendment to Term Loan Credit Agreement]

 

 

	
 
    	
GUARANTORS   (cont’d):
    
	
 
    	
 
    
	
 
    	
PHOENIX PHYSICIANS, LLC
    
	
 
    	
STREAMLINED MEDICAL   SOLUTIONS LLC
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
By: EMCARE, INC.,   as Sole Member of Phoenix Physicians, LLC and Streamlined Medical Solutions   LLC
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
By: 
    	
/s/ Craig A. Wilson
    
	
 
    	
 
    	
Name: 
    	
Craig A. Wilson
    
	
 
    	
 
    	
Title:
    	
Secretary
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
PINNACLE CONSULTANTS   MID-ATLANTIC, L.L.C.
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
By: 
    	
/s/ Craig A. Wilson
    
	
 
    	
 
    	
Name: 
    	
Craig A. Wilson
    
	
 
    	
 
    	
Title:
    	
Secretary
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
PROVEN   HEALHCARE SOLUTIONS OF NEW JERSEY, LLC
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
By: 
    	
/s/ Craig A. Wilson
    
	
 
    	
 
    	
Name: 
    	
Craig A. Wilson
    
	
 
    	
 
    	
Title:
    	
Secretary
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
PROVIDACARE, L.L.C.
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
By: AMERICAN MEDICAL   PATHWAYS, INC., as Sole Member of ProvidaCare, L.L.C.
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
By: 
    	
/s/ Craig A. Wilson
    
	
 
    	
 
    	
Name: 
    	
Craig A. Wilson
    
	
 
    	
 
    	
Title: 
    	
Secretary
    

 

[Signature Page to Second Amendment to Term Loan Credit Agreement]

 

 

	
 
    	
GUARANTORS   (cont’d):
    
	
 
    	
 
    
	
 
    	
REGIONAL EMERGENCY   SERVICES, L.P.
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
By: FLORIDA EMERGENCY   PARTNERS, INC., as General Partner of Regional Emergency Services, L.P.
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
By: 
    	
/s/ Craig A. Wilson
    
	
 
    	
 
    	
Name: 
    	
Craig A. Wilson
    
	
 
    	
 
    	
Title:
    	
Secretary
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
ROSE RADIOLOGY, LLC
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
By: SPOTLIGHT HOLDCO   LLC, as Sole Member of Rose Radiology, LLC
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
By:EMCARE, INC.,   as Sole Member of EmCare, Inc.
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
By: 
    	
/s/ Craig A. Wilson
    
	
 
    	
 
    	
Name: 
    	
Craig A. Wilson
    
	
 
    	
 
    	
Title:
    	
Secretary
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
SEAWALL ACQUISITION,   LLC
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
By: 
    	
/s/ Craig A. Wilson
    
	
 
    	
 
    	
Name: 
    	
Craig A. Wilson
    
	
 
    	
 
    	
Title:
    	
Secretary
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
SPOTLIGHT HOLDCO LLC
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
By: 
    	
/s/ Craig A. Wilson
    
	
 
    	
 
    	
Name: 
    	
Craig A. Wilson
    
	
 
    	
 
    	
Title:
    	
Secretary
    
					

 

[Signature Page to Second Amendment to Term Loan Credit Agreement]

 

 

	
 
    	
GUARANTORS   (cont’d):
    
	
 
    	
 
    
	
 
    	
SUN DEVIL ACQUISITION LLC
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
By: 
    	
/s/ Craig A. Wilson
    
	
 
    	
 
    	
Name: 
    	
Craig A. Wilson
    
	
 
    	
 
    	
Title:
    	
Secretary
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
TEMPLETON READINGS, LLC
    
	
 
    	
 
    
	
 
    	
 
    	
By: EMCARE, INC.,   as Sole Member of Templeton Readings, LLC
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
By: 
    	
/s/ Craig A. Wilson
    
	
 
    	
 
    	
Name: 
    	
Craig A. Wilson
    
	
 
    	
 
    	
Title:
    	
Secretary
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
WHITAKER PHYSICIANS   SERVICES, L.L.C.
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
By: 
    	
/s/ Craig A. Wilson
    
	
 
    	
 
    	
Name: 
    	
Craig A. Wilson
    
	
 
    	
 
    	
Title:
    	
Secretary
    

 

[Signature Page to Second Amendment to Term Loan Credit Agreement]

 

 

ACKNOWLEDGEMENT

 

Deutsche Bank AG New York Branch, as ABL Agent under that certain Intercreditor Agreement dated as of May 25, 2011 (the “Intercreditor Agreement”) and Deutsche Bank AG New York Branch, as Term Loan Agent under the Intercreditor Agreement hereby acknowledge that the issuance of the Tranche B-2 Term Loans will constitute Term Loan Obligations (as defined in the Intercreditor Agreement), under the Original Term Loan Credit Agreement (as defined in the Intercreditor Agreement).

 

	
 
    	
DEUTSCHE BANK AG NEW   YORK BRANCH
    
	
 
    	
in its capacity as ABL   Agent
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
By:
    	
/s/ Michael Winters
    
	
 
    	
Name: 
    	
Michael Winters
    
	
 
    	
Title: 
    	
Vice President
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
By: 
    	
/s/ Peter Cucchiara
    
	
 
    	
Name: 
    	
Peter Cucchiara
    
	
 
    	
Title: 
    	
Vice President
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
DEUTSCHE BANK AG NEW   YORK BRANCH
    
	
 
    	
in its capacity as Term   Loan Agent
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
By:
    	
/s/ Michael Winters
    
	
 
    	
Name: 
    	
Michael Winters
    
	
 
    	
Title: 
    	
Vice President
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
By: 
    	
/s/ Peter Cucchiara
    
	
 
    	
Name: 
    	
Peter Cucchiara
    
	
 
    	
Title: 
    	
Vice President
    

 

[Signature Page to Second Amendment to Term Loan Credit Agreement]Exhibit 10.2

 

EMPLOYMENT AGREEMENT

 

This Employment Agreement (the “Agreement”) by and between Envision Healthcare Corporation (the “Company” or “Envision”) and Thomas F. Bongiorno (the “Executive”) is made and entered into this 26th day of October 2015, effective as of the date set forth below.

 

RECITALS

 

Executive desires to be employed by the Company in a confidential relationship during which Executive will have access to and become familiar with information as to the specific manner of doing business, strategic plans for future business and identity of customers and potential customers of the Company and its subsidiaries, affiliates and managed entities, all of which is established and maintained at great expense to the Company and constitutes trade secrets and valuable goodwill of the Company; and

 

Executive recognizes that the Company and its subsidiaries and managed entities depend upon this confidential information and trade secrets, including, without limitation, confidential techniques, methods and data; and

 

The Company and its subsidiaries and managed entities will sustain great loss and damage if Executive should violate the provisions of this Agreement, particularly with respect to confidential information and restrictions on competition.  Monetary damages for such losses would be extremely difficult to measure.

 

NOW THEREFORE, in consideration of the mutual promises, terms, covenants and conditions set forth herein and the performance of each, effective as of the time of the effective date, it is hereby agreed as follows:

 

1.                                      Employment.

 

A.                                    The Company shall employ the Senior Vice President and Chief Accounting Officer and the Executive shall serve in such capacity, performing such duties as are consistent with his position, along with such other duties and responsibilities reasonably assigned to the Executive by the Company for employees of equivalent position. The Executive shall devote his best efforts and substantially all of his business time to the performance of his duties under this Agreement and shall perform them faithfully, diligently, competently and in a manner consistent with the policies of the Company as determined from time to time by the Company.

 

B.                                    The Executive shall report to the CFO/COO of Envision Healthcare Corporation (“Envision”) on all matters pertaining to his duties under this Agreement.

 

C.                                    The Executive shall not engage in other business activities outside the scope of this Agreement if such activities would detract from or interfere with the fulfillment of his responsibilities or duties under this Agreement.

 

D.                                    The Executive shall not serve as an officer or director (or the equivalent position) of any entity other than Company or its affiliated entities, and shall not receive fees or other remuneration for work performed either within or outside the scope of his or her employment without the prior written consent of the CFO/COO of Envision.

 

1

 

2.                                      Term of Employment. This Agreement shall commence on October 26, 2015 (the “Effective Date”), shall continue for a period of one (1) year, and shall automatically renew for additional one (1) year periods thereafter, unless either party provides the other with notice of termination pursuant to paragraph 7 of this Agreement.

 

3.                                      Compensation.

 

A.                                    As full compensation for all services rendered by the Executive pursuant to this Agreement, the Company shall pay to the Executive the sum of Three Hundred Twenty-Five Thousand Dollars ($325,000.00) annually (“Base Salary”), less all applicable withholdings.  The Base Salary shall be payable in twenty-six (26) equal installments of approximately Twelve Thousand Five Hundred Dollars ($12,500.00), on a bi-monthly basis or in accordance with such other payroll practice as may be in place from time, and shall be reviewed by the CFO/COO of Envision annually during the Company’s normal review period.

 

B.                                    Executive shall also be eligible to participate in the Company’s performance bonus plan, the Management and Exempt Incentive Plan (“Incentive Plan”), with a target bonus of 50% of Executive’s Base Salary for a full year of employment.  The Executive’s right to receive any bonus under the Incentive Plan shall be determined based upon the terms of the Incentive Plan and Executive’s achievement of performance targets established by the CFO/COO of Envision, such achievement determined at Envision’s sole discretion in accordance with the provisions of the Incentive Plan approved by the Board of Directors (the “Board”) of Envision Healthcare Holdings, Inc. (“EVH”).  Executive’s Incentive Plan bonus shall be paid in accordance with the terms and conditions of the Incentive Plan, which may be modified, suspended, or terminated at any time at the sole discretion of the CFO/COO of Envision but in no event shall the bonus, if any, be paid later than March 15 following completion of the applicable fiscal year, provided that Executive must be employed by Company on the date payment is to be made in order to be eligible for such payment.

 

4.                                      Fringe Benefits; Expenses.

 

A.                                    The Executive shall be entitled to participate in all health and related employee benefit plans applicable to the Company, on a basis consistent with the terms of such plans as offered to Company executives generally, to the extent he is eligible under the terms of such plans.

 

B.                                    The Executive shall be entitled to vacation time in accordance with the Company’s established vacation policies, to be taken at times selected by him, with the prior concurrence of the CFO/COO of Envision.

 

2

 

5.                                      Disability or Death.

 

A.                                    If, as the result of any physical or mental disability, the Executive shall have failed or is unable to perform his duties for a period of one hundred eighty (180) consecutive days, as determined by the Company, the Company may terminate this Agreement as of the date of its issuance of written notice without any further payment or the furnishing of any benefit by the Company under this Agreement, unless otherwise required by applicable law.  During the period of disability, and prior to notification of termination by the Company as set forth in this paragraph, Executive shall be entitled to receive his base salary and a pro rata portion of his annual performance bonus, to the extent he is eligible, offset by such amounts paid to Executive under any disability insurance policies maintained by the Company.

 

B.                                    The term of the Executive’s employment under this Agreement shall terminate upon his death without any further payment or the furnishing of any benefit by the Company under this Agreement other than accrued and unpaid base salary and commissions and expenses and benefits which have accrued pursuant to any plan or by law.

 

6.                                      Restrictive Covenants; Confidentiality; Inventions.

 

A.                                    Executive’s Restrictive Covenant.  Executive hereby recognizes and acknowledges that Company will incur substantial costs in providing the equipment, support services, personnel, management, administration, and other items and services that are necessary to assist Executive in his performance of the services which are the subject matter of this Agreement and that in the process of providing services under this Agreement, Executive will be provided Confidential Information (as defined below).  Executive further agrees and acknowledges that the Covenant Not to Compete described hereunder is necessary for the protection of Company and that Company would not have entered into this Agreement without the Covenant Not to Compete.  Solely for purposes of this Section 6 (unless otherwise specified in this Agreement), the term “Company” shall, in addition to Evolution, also include EVH, and the Company’s and EVH’s subsidiaries, affiliates, parent companies and companies under management agreements with any of them.

 

B.                                    Covenant Not to Compete.  In consideration of the provision of such Confidential Information, Executive covenants and agrees that during the Term of this Agreement and for 18 months thereafter, Executive will not directly or indirectly:

 

i.                                          Interference.  Either on his own account or for any other person, solicit, induce, attempt to induce, interfere with, or endeavor to cause any: (a) customer of Company to modify, amend, terminate, or otherwise alter any agreement with Company; or (b) employee or independent contractor engaged by Company to terminate employment or any other agreement or arrangement with Company. The prohibition on interference shall apply regardless of the defined Restriction Period.

 

ii.                                       Customers.  Enter into any agreement or relationship to provide executive or similar administrative services with any hospital currently under contract with Company, or any other customer to which Company has presented a formal proposal to provide services during the Term of this Agreement, without Company’s prior written consent.

 

3

 

iii.                                    Ownership or Affiliation with Competitors.  Own, manage, operate, maintain, engage in, serve as an advisor, employee or consultant for, control, or otherwise participate in or be involved as a shareholder, member, partner, guarantor, or other holder of a financial interest in, or have any other interest in, or enter into a services or management agreement or relationship with, any person or entity providing medical transportation services, post-acute care medical services, or physician practice management services as related to hospital based physician services with any governmental authority, entity, provider, or hospital with which Executive has come into contact while an employee of the Company, during any period of time that Executive is receiving compensation from Company either by salary or severance.  The restriction contained in this section shall not apply to ownership as a passive investor of less than a one percent (1%) interest in the outstanding equity securities of any publicly held corporation listed on a national securities exchange or association.

 

iv.                                   Advancement of Competitor’s Interest.  During the Term of this Agreement, make any statement or perform any act intended to advance an interest of any existing or prospective competitor of Company or encourage any other person or entity to make any such statement or to perform any such act.

 

v.                                      Solicitations for Competition.  Make any statement or perform any act intended to cause any existing or potential client of Company to use the services or purchase the products of any competitor, or otherwise to solicit, divert, take away or interfere with any of the accounts, trade, business patronage, employees or contractual arrangements of Company during any period of time that Executive is receiving compensation from Company either by salary or severance.  In the event that Executive is no longer receiving any compensation from Company, this restriction shall no longer apply, subject to the restrictions set forth in Sections 6(B)(i) and 6(B)(ii).

 

vi.                                   Extension of Non-Compete Period.  In the event that Executive violates the Covenant Not to Compete, then notwithstanding any provision herein to the contrary the Non-Compete Period shall be extended day for day for the time period that Executive is in violation of the Covenant Not to Compete.

 

vii.                                No Conflict.  Notwithstanding anything herein, this Section 6 shall not be deemed to be in conflict with any similar or corresponding provision and each one shall be valid and enforceable independent of the other.

 

C.                                    Reformation.   If a court of competent jurisdiction determines that this Section 6 is partially or wholly inoperative, invalid or unenforceable in a particular case because of its duration, geographical scope, restricted activity or any other parameter, such court shall reform such duration, geographical scope, restricted activity or other parameter with respect to such case to permit enforcement of such reformed Section 6 to the greatest extent allowable.

 

D.                                    Ancillary Agreement.  This Section 6 shall be construed as an agreement ancillary to the other provisions of this Agreement and the existence of any claim or cause of action of Executive against Company, whether predicated on this Agreement or otherwise, shall not constitute a defense to the enforcement by Company of this Section 6.  Any breach or violation of this Section 6 shall entitle Company to an injunction restraining any further

 

4

 

or continued breach or violation without posting a bond.  Such right to an injunction shall be in addition to and cumulative of (and not in lieu of) any other remedies to which Company is entitled because of such breach or violation.

 

E.                                     Confidentiality.           The Executive will not disclose any Confidential Information (as defined below) of the Company without the Company’s express written authorization, such Confidential Information will not be used in any way directly or indirectly detrimental to the Company, and the Executive will keep such Confidential Information confidential.  If the Executive is requested or required by legal process to disclose or produce any Confidential Information furnished in the course of his employment with the Company, the Executive will consult and cooperate with the Company as to the advisability of the Company taking legally available action to resist or narrow such request.  For the purposes of this Section 6, the term “Confidential Information” shall mean any knowledge or business information of Company (whether written or oral), including all business management or economic studies, patient lists, customer lists, employee lists, proprietary forms, proprietary business or management methods, data, techniques, fee schedules, or trade secrets of the Company whether or not such Confidential Information is disclosed or otherwise made available to the Executive.  Confidential Information shall also include the terms and provisions of this Agreement and any transaction or document otherwise executed by the parties to this Agreement.  The terms and provisions of this Section shall survive the termination of this Agreement.   Executive shall disclose only that portion thereof required to be disclosed and shall take all reasonable efforts to preserve the confidentiality thereof, including, without limitation, supporting Company (at Company’s expense) in intervention in such judicial, administrative or governmental proceeding.  Executive agrees to deliver to Company upon termination or otherwise upon request, all documents, memoranda, notes, plans, records, reports and other documentation, models, components, devices or computer software, whether embodied in a disk or in other form (and all copies of all of the foregoing), that contain Confidential Information and any other Confidential Information that Executive (or any affiliate of Executive) may then possess or have under his control.  Executive recognizes the proprietary interest of Company in the Confidential Information and agrees that a material breach of this Agreement shall occur if Executive or any of his affiliates violate any provision of this Section 6.

 

F.                                      Inventions.  Executive hereby assigns and agrees to assign all his or her interest in any and all conceptions and ideas for inventions, improvements, discoveries and works, whether or not patentable or copyrightable, which are conceived or made by Executive solely or jointly with another during the period of employment or within one (1) year thereafter and which are related to the business or activities of the Company or which Executive conceives as a result of his or her employment by the Company (collectively, “Proprietary Rights”), to the Company or its nominee.  All copyrightable Propriety Rights shall be considered to be “works made for hire”.  Whenever requested to do so by the Company, Executive shall execute any and all instruments and do such acts that the Company shall request to protect the Company’s interest therein.  These obligations shall continue beyond the termination of employment, and shall be binding upon Executive’s assigns, executors, administrators and other legal representatives.

 

5

 

7.                                      Termination.

 

A.                                    The Company shall have the right to immediately terminate this Agreement and the Executive’s employment with the Company for cause. For purposes of this Agreement, the term “cause” shall mean:

 

i.                                          Any material breach of the Executive’s obligations under this Agreement.

 

ii.                                       Fraud, theft, or gross misconduct on the part of the Executive, including, without limitation, criminal conduct, conduct involving moral turpitude, embezzlement, or misappropriation of assets.

 

iii.                                    Executive’s exclusion from participation in, or imposition of penalties from, any governmental reimbursement program, including but not limited to Medicare, Medicaid or Tri-Care.

 

iv.                                   Alcohol or drug abuse that impairs the Executive’s ability to properly perform his duties.

 

v.                                      Conduct by Executive which has a material adverse effect on the business of the Company or any of its subsidiaries, divisions, parent companies or affiliates, as determined by the Company.

 

vi.                                   Violation by the Executive of any of the written work rules or written policies of the Company, including the Company’s Corporate Compliance Policy.

 

B.                                    The Company may also terminate this Agreement without cause by providing the Executive with ninety (90) days prior written notice.

 

C.                                    Executive may terminate his employment at any time by providing ninety (90) days’ prior written notice of termination of this Agreement to the Company.

 

D.                                    If the employment of the Executive is terminated for cause, the Company shall have no obligation to make any further payment to the Executive (other than accrued and unpaid base salary and expenses to the date of termination), or continue to provide any benefit (other than benefits which have accrued pursuant to any plan or by law) to the Executive under this Agreement.

 

E.                                     Upon termination of Executive’s employment by the Company pursuant to paragraph 7.B, Executive shall be entitled to receive (i) all cash compensation earned under this Agreement to the date of termination plus (ii) Base Salary in the amount payable on the date immediately prior to termination for an additional period of eighteen (18) months following the date of termination; and (iii) a pro rata portion of his annual performance bonus under the Incentive Plan, if any, earned up to the date of such termination; provided that, such payment pursuant to this subsection (iii) shall be paid on the same date as the Company pays its other bonuses to employees of equivalent position.

 

6

 

8.                                      Miscellaneous.

 

A.                                    This Agreement shall be governed by and construed in accordance with the laws of the State of Colorado applicable to agreements made and performed in Colorado, and shall be construed without regard to any presumption or other rule requiring construction against the party causing the Agreement to be drafted.

 

B.                                    This agreement contains a complete statement of all the arrangements between the Company and the Executive with respect to its subject matter, supersedes all previous agreements, written or oral, among them relating to its subject matter, and cannot be modified, amended, or terminated orally. Amendments may be made to this Agreement at any time if mutually agreed upon in writing.

 

C.                                    Any amendment, notice, or other communication under this Agreement shall be in writing and shall be considered given when received and shall be delivered personally or mailed by Certified Mail, Return Receipt Requested, to the parties at their respective addresses set forth below (or at such other address as a party may specify by notice to the other):

 

	
If to Company:
    	
 
    	
6200 South Syracuse Way, Suite 200
    
	
 
    	
 
    	
Greenwood Village, Colorado 80111
    
	
 
    	
 
    	
Attention:              Legal   Department
    
	
 
    	
 
    	
 
    
	
If to Executive:
    	
 
    	
Executive’s last known address on file with Company
    

 

D.                                    The failure of a party to insist upon strict adherence to any term of this Agreement on any occasion shall not be considered a waiver or deprive that party of the right thereafter to insist upon strict adherence to that term or any other term of this Agreement. Any waiver must be in writing.

 

E.                                     The invalidity or unenforceability of any term or provision of this Agreement shall not affect the validity or enforceability of the remaining terms or provisions of this Agreement which shall remain in full force and effect and any such invalid or unenforceable term or provision shall be given full effect as far as possible. If any term or provision of this Agreement is invalid or unenforceable in one jurisdiction, it shall not affect the validity or enforceability of that term or provision in any other jurisdiction.

 

F.                                      This Agreement is not assignable by either party except that it shall inure to the benefit of and be binding upon any successor to the Company by merger or consolidation or the acquisition of all or substantially all of the Company’s assets, provided such successor assumes all of the obligations of the Company, and shall inure to the benefit of the heirs and legal representatives of the Executive.

 

G.                                    The parties acknowledge that none of the benefits granted to either party here under are conditioned on any requirement that either party make referrals to, be in a position to make or influence referrals to, or otherwise generate business for the other.

 

7

 

IN WITNESS WHEREOF, Company and Executive have executed this Agreement, in multiple counterparts, each of which shall be deemed an original, effective the day and year first above written.

 

 

	
 
    	
Thomas F. Bongiorno
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By: 
    	
/s/ Thomas F. Bongiorno
    
	
 
    	
 
    	
Thomas F. Bongiorno
    
	
 
    	
 
    
	
 
    	
Date of Execution: 
    	
10/30/15
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
ENVISION HEALTHCARE   CORPORATION
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/ William A. Sanger
    
	
 
    	
 
    	
William A. Sanger,   Chief Executive Officer
    
	
 
    	
 
    
	
 
    	
Date of Execution: 
    	
10/30/15
    
				

 

8

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00250-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00250-of-00352.parquet"}]]